Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001033427-18-000003
Filing Date
2018-01-08
Accepted
2018-01-08 16:39:21
Documents
2

Document Format Files

Seq Description Document Type Size
1 eaglepharm13g12312017.htm SC 13G 71840
2 eaglepharmex99.htm EX-99 8207
  Complete submission text file 0001033427-18-000003.txt   81617
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Subject) CIK: 0000827871 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88022 | Film No.: 18516859
SIC: 2834 Pharmaceutical Preparations

Mailing Address 276 POST ROAD WEST WESTPORT CT 06880-4704
Business Address 276 POST ROAD WEST WESTPORT CT 06880-4704 2033417800
IRIDIAN ASSET MANAGEMENT LLC/CT (Filed by) CIK: 0001033427 (see all company filings)

EIN.: 061439577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G